A comparison of the relative costs of the injectable contraceptive (de
pot medroxyprogesterone acetate) and the hormonal implant (Norplant(R)
) indicates that the implant is a less costly contraceptive option whe
n it is used for its full five-year lifespan. Over a five-year period,
the implant costs $107 annually, compared with $140 per year for the
injectable. However, if a woman discontinues the implant before she ha
s used it for at least four years, the injectable becomes the less cos
tly option. Relatively high continuation rates-around 95% annually-are
necessary to make the implant the more cost-effective contraceptive m
ethod.